Abstract:Background: In stent restenosis (ISR) is one of the major complications after stent implantation. Thus, there is a growing interest in identifying a biomarker for the onset of ISR. High levels of serum homocysteine (Hcy) have been associated with the progression of cardiovascular disease. Therefore, the study was carried out to quantify the correlation between serum Hcy and ISR severity. Compared with coronary angiography (CAG), Hcy levels provided a significantly better clinical detection of ISR severity after PCI.Methods: A total of 155 patients were recruited from Shanxi Bethune hospital, from 6 months to 2 years post PCI. Serum Hcy levels and postoperative angiography results were used to differentiate the patients into two experimental groups: ISR (>50% diametrical stenosis), and non-ISR. The non-ISR included two subgroups: intimal hyperplasia (10–50% diametrical stenosis), and recovery (<10% diametrical stenosis). In addition, a group of 80 healthy individuals was used as a negative control. The correlation between homocysteine level and ISR severity t was analyzed for all groups. In addition, the correlation between serum Hcy level and the severity of ISR in the experimental group was analyzed by the Pearson correlation test.Results: The serum Hcy level in the experimental group and control group was determined to be (20.21 ± 11.42) μmol/L and (15.11 ± 10.25) μmol/L respectively. The level of serum Hcy in the experimental group was significantly higher than in the control group (t-value of 2.385; p-value of 0.019). The serum Hcy level in the restenosis and the intimal hyperplasia group was (25.72 ± 13.71) μmol/L and (17.35 ± 7.70) μmol/L respectively. The serum Hcy level in the restenosis group was significantly higher than in the intimal hyperplasia group (t-value of 2.215; p-value of 0.033). The level of serum Hcy in the group without a plaque in the stent was (16.30 ± 6.08) μmol/L, whereas in the control group was (15.11 ± 10.25) μmol/L. The no plaque group had a slightly higher serum Hcy level than the control group (t-value of 0.634; p-value of 0.528). All included patients were divided into four quartiles based on the serum Hcy concentration: quartile 1 (8.90–13.20 μmol/L), quartile 2 (13.30–16.45 μmol/L), quartile 3 (16.60–24.25 μmol/L) and quartile 4 (24.30-65.30 μ mol/L). The incidence of ISR was 5, 6.25, 7.5 and 15%, in the 1,2,3 and four quartiles respectively. The serum Hcy level in the experimental group was (20.21 ± 11.42) μmol/L, the severity of in-stent restenosis was (0.25 ± 0.31), (R-value was 0.234; p-value was 0.037), indicating a correlation between serum Hcy and the severity of restenosis (p < 0.05). Taking coronary angiography as the gold standard, a ROC curve analysis was performed on the serum Hcy levels for the experimental group. The area under the curve (AUC) was 0.718 (95% CI 0.585-0.854, p < 0.001), indicating that the serum Hcy concentration could predict ISR. On the ROC curve, the best critical value of serum Hcy concentration for predicting ISR was 20.05 μmol/L, with a sensitivity of 45% and specificity of 88.1%.Conclusion: A positive correlation was observed between homocysteine and the severity of restenosis after PCI, The level of Hcy could serve as a predictive biomarker for the severity of ISR.

The Relationship Between the Levels of Plasma Homocysteine and the Restenosis of Intracranial or Extracranial Artery Before and after Stent Implantation

Level of plasma homocysteine before and after stent-assisted angioplasty of intracranial and extracranial arteries

To Explore the Relationship between Clinical Serum Markers and Intracoronary in-stent Restenosis

The Serum Levels of High Sensitivity C-reactive Protein and Cardiac Events after Percutaneous Coronary Intervention

The Relationship of Homocysteine Levels to Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Acute Coronary Syndrome Patients

Serum Homocysteine Level Predictive Capability for Severity of Restenosis Post Percutaneous Coronary Intervention

Association of Elevated Plasma Homocysteine Level with Restenosis and Clinical Outcomes After Percutaneous Coronary Interventions: a Systemic Review and Meta-analysis

The Relationship Between the Plasma Homocysteine and Intracranial Artery Stenosis in Patients with Cerebral Infarction

The Prognostic Value of Serum Homocysteine Level in Patients with Acute Myocardial Infarction after Primary Percutaneous Coronary Intervention

Correlation between the dynanic changes of serum high-sensitivity Creactive protein and restenosis after internal carotid artery stenting

Relationship Between Levels of Serum IL-1β and IL-1Ra and Restenosis in Patients with Intra and Extra-Cranial Arteriostenosis after Stent-Assisted Angioplasty

Correlation Between the Dynamic Changes of Senlm High-Sensitivity Creactive Protein and Restenosis after Internal Carotid Anery Stenting

The Clinical Study of Relationship Between Plasma Homocysteine and Severity of Coronary Artery Lesion

Higher Serum Cystatin C and Matrix Metalloproteinase 9 Levels Effectively Predict In-Stent Restenosis after Stent Implantation for Intracranial and Extracranial Arterial Stenosis

Relationship Between Uric Acid Levels in Patients with Acute Ischemic Stroke and Discharged Outcome

Influence of the Level of Hb-Egf in Serum on Instent Restenosis after Chd Stenting

Relationship of Preprocedural High Sensitivity C-reactive Protein and Restenosis after Coronary Angioplasty of Unprotected Left Main Coronary Artery Stenosis

Effect of hyperhomocysteine in patients after PCI for non-ST-segment elevation myocardial infarction, a retrospective study

The Value of Preprocedural Serum Levels of C-reactive Protein in Predicting Cardiovascular Events and Restenosis after Coronary Stent Implantation

Relationship between plasma homocysteine and carotid atherosclerotic plaques in patients with ischemic cerebrovascular disease

Relationship between association of plasma homocysteine and coronary artery stenosis in population with coronary artery dis-ease